186 related articles for article (PubMed ID: 35355731)
1. Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database.
Guo K; Feng Z; Chen S; Yan Z; Jiao Z; Feng D
Front Pharmacol; 2022; 13():848472. PubMed ID: 35355731
[No Abstract] [Full Text] [Related]
2. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Oh S; Byeon SJ; Chung SJ
J Psychopharmacol; 2022 Sep; 36(9):1041-1050. PubMed ID: 35695641
[TBL] [Abstract][Full Text] [Related]
3. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.
Rani FA; Byrne PJ; Murray ML; Carter P; Wong IC
Drug Saf; 2009; 32(4):325-33. PubMed ID: 19388723
[TBL] [Abstract][Full Text] [Related]
4. Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database.
Jiao Z; Wang G; Feng Z; Yan Z; Zhang J; Li G; Wang Q; Feng D
Front Pharmacol; 2021; 12():760013. PubMed ID: 35145400
[No Abstract] [Full Text] [Related]
5. Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database.
Jiao Z; Feng Z; Yan Z; Zhang J; Li G; Wang G; Wang Q; Feng D
Front Oncol; 2021; 11():807171. PubMed ID: 34988029
[TBL] [Abstract][Full Text] [Related]
6. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
8. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
9. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
13. Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice.
Egberts KM; Gerlach M; Correll CU; Plener PL; Malzahn U; Heuschmann P; Unterecker S; Scherf-Clavel M; Rock H; Antony G; Briegel W; Fleischhaker C; Häge A; Hellenschmidt T; Imgart H; Kaess M; Karwautz A; Kölch M; Reitzle K; Renner T; Reuter-Dang SY; Rexroth C; Schulte-Körne G; Theisen FM; Walitza S; Wewetzer C; Fekete S; Taurines R; Romanos M
Pharmacopsychiatry; 2022 Sep; 55(5):255-265. PubMed ID: 35130562
[TBL] [Abstract][Full Text] [Related]
14. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
16. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
[TBL] [Abstract][Full Text] [Related]
18. Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study.
Cai Y; Yang L; Shangguan X; Zhao Y; Huang R
Front Pharmacol; 2021; 12():736618. PubMed ID: 34744720
[No Abstract] [Full Text] [Related]
19. [Analysis of drug safety information using large-scale adverse drug reactions database].
Morikawa K
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]